Pds Biotechnology (PDSB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PDSB Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Pds Biotechnology manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent5.60
Cash & Short-term Investments5.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.45
Total Current Assets7.05
Equipment/Property/Plant Net0.18
Prepaid Expense Other, Noncurrent PR1.55
Other Assets, Noncurrent0.04
Total Assets8.81
Liabilities
Accounts Payable, Current AC6.39
Accrued Liabilities, Current AC1.63
Secured Debt, Current LO4.32
Other Liabilities, Current0.03
Total Current Liabilities12.38
Long-term debt0.00
Secured Debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.01
Finance Lease Liability Current0.03
Total Liabilities12.39
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock230.11
Retained Earnings / Accumulated Deficit-233.71
Other Equity0.00
Common Stockholder's Equity-3.58
Total Stockholder's Equity-3.58
Liabilities & Stockholder's Equity8.81
4 historic quarters locked

Sign in to unlock the full Pds Biotechnology balance sheet history.

About Pds Biotechnology Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001140361-26-032824

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.